Cell transplantation for treatment of left-ventricular dysfunction due to ischemic heart failure: From bench to bedside

Expert Review of Cardiovascular Therapy

Volumn 5, Issue 1, 2007, Pages 125-131

  Nanjundappa, Aravinda ^a   Raza, Jaffar Ali ^a   Dieter, Robert S ^b   Mandapaka, Sangeeta ^a   Cascio, Wayne E ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Cells; Myocardial infarction; Remodeling; Transplantation progenitor cells

Indexed keywords

ADENOVIRUS VECTOR; GRANULOCYTE COLONY STIMULATING FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ANGIOMA; BONE MARROW TRANSPLANTATION; CELL CULTURE; CELL ISOLATION; CELL PROLIFERATION; CELL REGENERATION; CELL TRANSPLANTATION; CELL TYPE; CLINICAL PRACTICE; CLINICAL TRIAL; COMPUTER PROGRAM; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY OBSTRUCTION; DISEASE MODEL; ELECTROCARDIOGRAPHY; EMBRYONIC STEM CELL; GENE THERAPY; GRAFT REJECTION; HEART ARRHYTHMIA; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; HUMAN; IN-STENT RESTENOSIS; INFECTION; MAGNETIC FIELD; MALIGNANT NEOPLASTIC DISEASE; MEDICAL ASSESSMENT; MEDICAL RESEARCH; MESENCHYMAL STEM CELL TRANSPLANTATION; MYOBLAST; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT CARE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL TRANSPLANTATION; SYMPTOM; TERATOMA; THREE DIMENSIONAL IMAGING; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELL TRANSPLANTATION; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; HEART CATHETERIZATION; HUMANS; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NEOVASCULARIZATION, PHYSIOLOGIC; RECOVERY OF FUNCTION; STEM CELL TRANSPLANTATION; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 33846467636     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.5.1.125     Document Type: Review

References (43)

1. Erickson H. Heart Failure: A growing public health problem. J. Intern. Med. 237, 135-141 (1995).
2. American Heart association. 2002 Statistical update. Dallas, TX: American heart association.
3. Pfeffer JM, Pfeffer MA, Fltcher PF, Braunwald E. Progressive ventricular remodeling in rat with myocardial infarction. Am. J. Physiol 260, 1406-1414 (1991).
4. Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide after myocardial infarction. N. Engl. J. Med. 334, 1750-1757 (2001).
5. Anversa P, Nadal-ginard B. Myocyte renewal and ventricular remodeling. Nature 415, 240-243 (2002).
6. Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med. 346, 5-15 (2002).
7. Chachques JC, Shafy A, Duarte F et al. From dynamic to cellular cardiomyoplasty. J. Card. Surg. 17, 194-200 (2002).
8. Chiu RCJ. Therapeutic cardiac angiogenesis and myogenesis: The promises and challenges on a new frontier. J. Thorac. Cardiovasc. Surg. 122, 851-852 (2001).
9. Rajnoch C, Chachques JC, Berrebi A, Bruneval P, Benoit MO, Carpentier A. Cellular therapy reverses myocardial dysfunction. J. Thorac. Cardiovasc. Surg. 121, 871-878 (2001).
10. Glaser R, Lu MM, Narula N, Epstein JA. Smooth muscle cells, but not myocytes, of host origin in transplanted human hearts. Circulation 106, 17-19 (2002).
11. Mack CA, Patel SR, Schwartz, EA et al. Biologic bypass with the use of adenovirus mediated gene transfer of the deoxyribonucleic acid for VEGF12 improves myocardial perfusion and function in the ischemic porcine heart. J. Thorac. Cardiovasc. Surg. 115, 168-177 (1998).
12. Perin EC, Geng YJ, Willerson JT. Adult stem cell therapy in perspective. Circulation 107, 935-938 (2003).
13. Zhang YM, Hartzell C, Narlow M, Dudley SC Jr. Stem cell derived cardiomyocytes demonstrates arrhythmic potential. Circulation. 106, 1294-1299 (2002).
14. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pleuripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49 (2002).
15. Pagani FD, DerSimonian H, Zawadzka A et al. Autologous skeletal myoblasts transplanted to ischemia-damaged myocardium in humans. Histological analysis of cell survival and differentiation. J. Am. Coll Cardiol. 41, 879-888 (2003).
16. Dib N, McCarthy P, Campbell A et al. Two-year folow-up of the safety and feasibility of autologous myoblast transplantation in patients with ischemic cardiomyopathy: Results from the United States experience. Circulation 108, IV-623 (2003).
17. Monnet E, Chachques JC. Animal models of heart failure: What is new? Ann Thor Surg. 79, 1445-1453 (2005).
18. Swindle MM & Adams RJ. Experimental Surgery and Physiology. Induced Animal Models of human Disease. Williams & Wilkins, MD, USA (1988).
19. McGoon DC. The ongoing quest for ideal myocardial protection. A catalog of the recent English literature. J. Thorac. Cardiovasc. Surg. 89, 639-653 (1985).
20. 2+ channel blockers. Differentiation 48, 173-182 (1991).
21. Kawamoto A, Tkebuchava T, Yamaguchi J et al, Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107, 461-468 (2003).
22. Klug MG, Soonpaa MH, Koh GY et al. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98, 216-224 (1996).
23. Yokomuro H, Li RK, Mickle DA et al. Transplantation of cryopreserved cardiomyocytes. J. Thorac. Cardiovasc. Surg. 121, 98-107 (2001).
24. Ott HC, Davis BH, Taylor DA. Cell therapy for heart failure - muscle, bone marrow, blood, and cardiac-derived stem cells. Semin. Thorac. cardiovasc. Surg. 17, 348-360 (2005).
25. Orlic D, Kajstura J, Chimenti S et al, Bone marrow cells regenerate infarcted myocardium. Nature 410, 701-705 (2001).
26. Toma C, Pittenger ME, Cahill KS et al. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105, 93-98 (2002).
27. Perin EC, Silva GV, Sarmento-Leite R et al Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: Validation by delayed-enhancement magnetic resonance imaging. Circulation. 106, 957-961 (2002).
28. Perin EC, Silva GV, Leite RS. Left ventricular electromechanical mapping as a diagnostic method. In: Myocardial Revascularization: Novel Percutaneous Approaches. Abela GS (Ed.). Wiley-Liss, NY, USA 183-195 (2001).
29. Gepstein L. Hayam G. Shpun S. Ben-Haim SA. Hemodynamic evaluation of the heart with a nonfluoroscopic electromechanical mapping technique. Circulation. 96, 3672-3680 (1997).
30. Chachques JC. Acar C. Herreros J et al Cellular cardiomyoplasty: clinical application. Ann. Thorar. Surg., 77, 1121-1130 (2004).
31. Miller PJ. An elastic stain. Med. Lab. Technol 28, 148-149 (1971).
32. Herreros J, Prosper F, Perez A et al. Autologous intramyocardial injection of cultured skeletal muscle-derived stem cells in patients with non-acute myocardial infarction. Europ. Heart J. 24, 2012-2020 (2003).
33. Steendijk P, Smits PC, Valgimigli M, van der Giessen WJ, Onderwater EE, Serruys PW. Inttramyocardial injection of skeletal myoblasts: Long-term follow-up with pressure-volume loops. Nat. Clin. Pract. Cardiovasc. Med. 3(Suppl. 1), S94-S100 (2006).
34. Dohmann HF, Perin EC, Tahiya CM et al. Transendocardial autologous bone marrow mononuclear cell injection in ischemic heart failure: Postmortem anatomicopathologic and immunohistochemical findings. Circulation. 112, 521-526 (2005).
35. Strauer BE, Brehm M, Zeus T et al. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106, 1913-1918 (2002).
36. Tse HF, Kwong YL, Chan JK et al. Angiogenesis in ischemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet 361, 47-49 (2003).
37. Wollert KC, Meyer GP, Lotz J et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet. 364(9429), 141-148 (year).
38. Kang HJ, Kim HS, Zhang SY et al. Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: The MAGIC cell randomized clinical trial. Lancet 363, 746-747 (2004).
39. Stamm C, Westphal B, Kleine HD et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361, 45-46 (2003).
40. Assmus B, Schächinger V, Teupe C et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation. 106, 3009-3017 (2002).
41. Perin E, Dohmann HF, Borojevic R et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure. Circulation. 107, 2294-2302 (2003).
42. Epstein SE, Kornowski R, Fuchs S et al. Angiogenesis therapy. amidst the hype, the neglected potential for serious side effects. Circulation. 104, 115 (2001).
43. Menasche P, Desnos M. Cardiac reparation: Fixing the heart with cells, new vessels and genes. Eur. Heart J. 4, D73-D81 (2002).